Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma LaCasce, A. S., Bociek, G., Sawas, A., Caimi, P. F., Agura, E., Matous, J., Ansell, S., Crosswell, H., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O'Connor, O. A., Josephson, N., Advani, R. AMER SOC HEMATOLOGY. 2015
View details for Web of Science ID 000368021800239